Photo from wikipedia
In march 2021, fatal cases of thrombosis associated with thrombocytopenia following anti-SARS-CoV2 adenoviral vaccines administration have been reported especially in younger people, the so-called vaccineinduced thrombosis and thrombocytopenia (VITT).1 This… Click to show full abstract
In march 2021, fatal cases of thrombosis associated with thrombocytopenia following anti-SARS-CoV2 adenoviral vaccines administration have been reported especially in younger people, the so-called vaccineinduced thrombosis and thrombocytopenia (VITT).1 This has raised the challenge of accepting VITT-deceased patients as organ donors, taking into account potential risks associated with transplantation, such as the occurrence of microangiopathic thrombosis of the graft, or the development of transplant-mediated alloimmune thrombocytopenia (TMA).2 Here, we present two cases of kidney transplantation from donors deceased as a consequence of VITT. Data on more than 1-year followup, the longest available, are reported.
Journal Title: Transplant Infectious Disease
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!